These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 9784947)

  • 21. Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid.
    Strle F; Ruzić-Sabljić E; Cimperman J; Lotric-Furlan S; Maraspin V
    Clin Infect Dis; 2006 Sep; 43(6):704-10. PubMed ID: 16912943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of tests for detection of Borrelia burgdorferi sensu lato infection in patients with diagnosed borreliosis.
    Chmielewska-Badora J; Cisak E; Wójcik-Fatla A; Zwoliński J; Buczek A; Dutkiewicz J
    Ann Agric Environ Med; 2006; 13(2):307-11. PubMed ID: 17196006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved serodiagnostic testing for Lyme disease: results of a multicenter serologic evaluation.
    Craven RB; Quan TJ; Bailey RE; Dattwyler R; Ryan RW; Sigal LH; Steere AC; Sullivan B; Johnson BJ; Dennis DT; Gubler DJ
    Emerg Infect Dis; 1996; 2(2):136-40. PubMed ID: 8903216
    [No Abstract]   [Full Text] [Related]  

  • 24. Western blot banding pattern in early Lyme borreliosis among patients from an endemic region of north-eastern Poland.
    Flisiak R; Wierzbicka I; Prokopowicz D
    Rocz Akad Med Bialymst; 1998; 43():210-20. PubMed ID: 9972057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The polymerase chain reaction evaluation of Borrelia burgdorferi DNA presence in peripheral blood of patients with Lyme disease].
    Kondrusik M; Grygorczuk S; Skotarczak B; Wodecka B; Pancewicz S; Zajkowska J; Swierzbińska R; Hermanowska-Szpakowicz T
    Pol Merkur Lekarski; 2004 Dec; 17(102):593-6. PubMed ID: 15771130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neurological manifestations of Lyme disease].
    Baumgartner E; Friedli P; Erard P; Kaeser P
    Rev Med Suisse Romande; 1993 Nov; 113(11):873-84. PubMed ID: 8272713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Etiologic diagnosis of cases of autochthonous Borrelia burgdorferi infection (Lyme disease)].
    Crăcea E; Constantinescu S; Balaci L; Vizitiu O; Căruntu F; Căruntu V; Angelescu C; Streinu-Cercel A; Bocîrnea C; Pănoiu L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1988; 33(3):239-44. PubMed ID: 3249895
    [No Abstract]   [Full Text] [Related]  

  • 28. Aspects of the diagnosis of Lyme borreliosis.
    Karlsson M
    Scand J Infect Dis Suppl; 1990; 67():1-59. PubMed ID: 2371553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory considerations in the diagnosis and management of Lyme borreliosis.
    Golightly MG
    Am J Clin Pathol; 1993 Feb; 99(2):168-74. PubMed ID: 8438790
    [No Abstract]   [Full Text] [Related]  

  • 30. [Left sided sudden hemiparesis linked to a central form of Lyme disease].
    Deloizy M; Devos P; Stekelorom T; Testard D; Belhadia A
    Rev Neurol (Paris); 2000 Dec; 156(12):1154-6. PubMed ID: 11139733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant human granulocytic anaplasmosis and Lyme neuroborreliosis.
    Lotric-Furlan S; Ruzic-Sabljic E; Strle F
    Clin Microbiol Infect; 2009 Dec; 15 Suppl 2():28-9. PubMed ID: 19416290
    [No Abstract]   [Full Text] [Related]  

  • 32. Diagnosis and clinical characteristics of ocular Lyme borreliosis.
    Karma A; Seppälä I; Mikkilä H; Kaakkola S; Viljanen M; Tarkkanen A
    Am J Ophthalmol; 1995 Feb; 119(2):127-35. PubMed ID: 7832219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease.
    Kalish RA; McHugh G; Granquist J; Shea B; Ruthazer R; Steere AC
    Clin Infect Dis; 2001 Sep; 33(6):780-5. PubMed ID: 11512082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory tests for Lyme disease.
    Berger BW
    Dermatol Clin; 1994 Jan; 12(1):19-24. PubMed ID: 8143381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Criteria for evaluation of immunoblots using Borrelia afzelii, Borrelia garinii and Borrelia burgdorferi sensu stricto for diagnosis of Lyme borreliosis].
    Honegr K; Havlasová J; Gebouský P; Dostál V; Pellantová V; Skrabková Z; Hulínská D
    Epidemiol Mikrobiol Imunol; 2001 Nov; 50(4):147-56. PubMed ID: 11769176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lyme neuroborreliosis with acute meningitis as the presenting manifestation: report of a case].
    Sheng R; Wang A; Liu X
    Zhonghua Nei Ke Za Zhi; 1997; 36(1):21-4. PubMed ID: 9812556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serologic testing only part of Lyme diagnosis.
    Yost JH; Spencer-Green G
    J Am Osteopath Assoc; 1992 Oct; 92(10):1218-20. PubMed ID: 1459869
    [No Abstract]   [Full Text] [Related]  

  • 38. Protection from Lyme neuroborreliosis in nonhuman primates with a multiantigenic vaccine.
    Pachner AR; Delaney E; Zhang WF; O'Neill T; Major E; Frey AB; Davidson E
    Clin Immunol; 1999 Jun; 91(3):310-3. PubMed ID: 10370376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Validity of positive anti-Borrelia antibodies in the diagnosis of neuroborreliosis].
    García-Moncó JC
    Neurologia; 1992 Feb; 7(2):47-9. PubMed ID: 1610599
    [No Abstract]   [Full Text] [Related]  

  • 40. Latent Lyme neuroborreliosis: presence of Borrelia burgdorferi in the cerebrospinal fluid without concurrent inflammatory signs.
    Pfister HW; Preac-Mursic V; Wilske B; Einhäupl KM; Weinberger K
    Neurology; 1989 Aug; 39(8):1118-20. PubMed ID: 2668788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.